Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Congenital hypoplastic anemia

L K Diamond, W C Wang, B P Alter

    Advances in Pediatrics
    |January 1, 1976
    PubMed
    Summary
    This summary is machine-generated.

    Congenital hypoplastic anemia (CHA) is a rare erythrogenesis disorder. Corticosteroid treatment effectively induces remission in most patients, though long-term management is often necessary.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    VACTERL-H Association and Fanconi Anemia.

    Molecular syndromology·2013
    Same author

    Ineffectiveness of prophylactic epsilon aminocaproic acid in severe hemophilia.

    The New England journal of medicine·2011
    Same author

    Chemical, clinical and immunological studies on the products of human plasma fractionation; serum albumin as a diluent for Rh typing reagents.

    The Journal of clinical investigation·2010
    Same author

    Disease-specific hematopoietic cell transplantation: nonmyeloablative conditioning regimen for dyskeratosis congenita.

    Bone marrow transplantation·2010
    Same author

    Varieties of anti-Rh agglutinins; some of their characteristics.

    American journal of diseases of children (1911)·2010
    Same author

    Erythroblastosis foetalis or haemolytic disease of the newborn.

    Proceedings of the Royal Society of Medicine·2010
    Same journal

    Two Steps Forward-One Step Back: Keeping Pace with Advances.

    Advances in pediatrics·2025
    Same journal

    Pediatric Lymphadenopathy.

    Advances in pediatrics·2025
    Same journal

    Vascular and Gastrointestinal Access in Children.

    Advances in pediatrics·2025
    Same journal

    The Ouchless Pediatric Emergency Department.

    Advances in pediatrics·2025
    Same journal

    Seizures and Shaking in Newborns and Babies.

    Advances in pediatrics·2025
    Same journal

    Procalcitonin in Pediatric Emergency Medicine.

    Advances in pediatrics·2025
    See all related articles

    Area of Science:

    • Hematology
    • Pediatric Hematology
    • Red Blood Cell Disorders

    Background:

    • Congenital hypoplastic anemia (CHA) is a rare disorder of erythrogenesis affecting infants and children.
    • While onset can be late in gestation, severe anemia typically manifests within the first four months of life.

    Observation:

    • Associated congenital anomalies include growth retardation, webbed neck, and abnormal thumbs.
    • Red blood cell abnormalities resemble fetal erythrocytes rather than adult cells, persisting even after remission.

    Findings:

    • Re-examination of 175 cases reveals anemia is macrocytic (MCV 100-115 fL), not normocytic.
    • Corticosteroid therapy induces remission in 80% of patients, often requiring long-term, low-dose maintenance.

    Implications:

    Related Experiment Videos

    • Early corticosteroid treatment is crucial for managing CHA.
    • Persistent red cell abnormalities suggest a permanent defect in erythrogenesis, impacting long-term prognosis.